The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge

by Patrick Younan, Palaniappan Ramanathan, Jessica Graber, Fabian Gusovsky, Alexander Bukreyev, Stefanie N. Vogel, John T. Patton
Published 2017-04-01

A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.

by Meagan A Barry, Leroy Versteeg, Qian Wang, Jeroen Pollet, Bin Zhan, Fabian Gusovsky, Maria Elena Bottazzi, Peter J Hotez, Kathryn M Jones
Published 2019-05-01

Influenza “Trains” the Host for Enhanced Susceptibility to Secondary Bacterial Infection

by Kari Ann Shirey, Darren J. Perkins, Wendy Lai, Wei Zhang, Lurds R. Fernando, Fabian Gusovsky, Jorge C. G. Blanco, Stefanie N. Vogel
Published 2019-05-01

Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection

by Julio V. Cruz-Chan, Liliana E. Villanueva-Lizama, Leroy Versteeg, Ashish Damania, Maria José Villar, Cristina González-López, Brian Keegan, Jeroen Pollet, Fabian Gusovsky, Peter J. Hotez, Maria Elena Bottazzi, Kathryn M. Jones
Published 2021-02-01